Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

linde gas a.s. - kisik - medicinski plin, stisnjeni - kisik 22,4 % (v/v) / 1 jeklenka - medicinski zrak

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

linde gas a.s. - kisik - medicinski plin, stisnjeni - kisik 22,4 % (v/v) / 1 jeklenka - medicinski zrak

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

linde gas a.s. - kisik - medicinski plin, stisnjeni - kisik 22,4 % (v/v) / 1 jeklenka - medicinski zrak

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

linde gas a.s. - kisik - medicinski plin, stisnjeni - kisik 22,4 % (v/v) / 1 jeklenka - medicinski zrak

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

linde gas a.s. - kisik - medicinski plin, stisnjeni - kisik 22,4 % (v/v) / 1 jeklenka - medicinski zrak

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

linde gas a.s. - kisik - medicinski plin, stisnjeni - kisik 22,4 % (v/v) / 1 jeklenka - medicinski zrak

Evropska unija - slovenščina - EMA (European Medicines Agency)

medac gesellschaft für klinische spezialpräparate mbh - carmustine - hodgkin disease; lymphoma, non-hodgkin - antineoplastična sredstva - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).

Evropska unija - slovenščina - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - limfom, mantle cell - antineoplastična sredstva - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Evropska unija - slovenščina - EMA (European Medicines Agency)

vetoquinol - triptorelin acetate - hipofize in hipotalamični hormoni in analogi - pigs (sows for reproduction) - for the synchronisation of ovulation in weaned sows to enable a single fixed-time artificial insemination.

Evropska unija - slovenščina - EMA (European Medicines Agency)

mylan ireland limited - fingolimod hidroklorid - multiplo sklerozo, recidivno-nakazila - imunosupresivi - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older:patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 in 5. 1)orpatients s hitro razvijajočimi se hudo recidivno nakazila multiplo sklerozo, opredeljeno z 2 ali več onemogočanje zagonov v enem letu, in z 1 ali več gadolinium krepitev poškodbe na možganih, mri ali znatno povečanje t2 lezije obremenitvi, kot je v primerjavi s predhodnim zadnjih mri.